Pardes Biosciences, Inc. Stock
Equities
PRDS
US69945Q1058
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 59 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 59 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 18 M€ | +3.53% | - |
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.35B | |
+41.82% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |